Category

News
This article was originally published by Medical News Today Multiple myeloma is a type of blood cancer that affects plasma cells. Doctors use a three-step staging system to classify the severity of multiple myeloma and whether it has spread. A person may experience different types of symptoms in each stage, and survival rates will change...
Continue Reading
This article was originally posted by Journal of Experimental Pharmacology Offidani et al. Journal of Experimental Pharmacology 2021:13 245–264 Offidani, Corvatta, Morè & Olivieri Multiple myeloma (MM) is the second most frequent hematological malignancy characterized by bone marrow aberrant plasma cells proliferation leading to a genetic complex and heterogeneous disease, with a median survival ranging...
Continue Reading
Auckland Myeloma Patient Seminar, hosted by Myeloma New Zealand. We heard from Dr Henry Chan (Waitemata DHB), Dr Nicole Chien (Auckland DHB), Dr Ken Romeril and nursing staff from Auckland and North Shore Hospitals.
Continue Reading
This article was originally posted by targeted Oncology Case: A 75-Year-Old Man with Multiple Myeloma Initial Presentation A 75-year-old man presents with worsening fatigue on exertion, pallor, and hip painPMH: osteoarthritisPE: tired appearing male, poor hand-grip strength, mild tenderness on palpation of the left hipECOG 2 Clinical workup Hb 9.8 g/dL, corrected calcium 11.9mg/dL, LDH 295U/L,...
Continue Reading
This article was originally published on TheLimbic Australian experts have been ‘startled’ to discover that many patients with multiple myeloma do not receive recommended imaging and staging, sparking concerns about missed diagnoses and overtreatment of benign forms of the disease. The findings come from an analysis of real-world data of more than 2400 newly diagnosed...
Continue Reading
Myeloma Australia’s Medical and Scientific Advisory Group (MSAG) presents the article of the week. On behalf of Myeloma Australia’s Medical and Scientific Advisory Group (MSAG) please find below our article of the week. 3-year follow up of the phase III CASTOR study with independent expert commentary provided by MSAG chair Professor H. Miles Prince AM (Research...
Continue Reading
Welcome to issue 37 of Multiple Myeloma Research Review. This issue begins with a retrospective, multinational report describing the clinical features associated with outcomes of patients with MM who had acquired SARS-COV-2 infection. There is also research demonstrating that autologous HSCT is an important therapy among patients with MM, even our elderly patients. Researchers from...
Continue Reading
Come along to our Auckland Myeloma Patient Seminar, hosted by Myeloma New Zealand.  We will hear from Dr Henry Chan (Waitemata DHB), Dr Nicole Chien (Auckland DHB), Dr Ken Romeril and nursing staff from Auckland and North Shore Hospitals.
Continue Reading
This article was originally published on Cure While a diagnosis of multiple myeloma can be overwhelming for patients, the disease is very treatable, according to Dr. Andrew Yee. At CURE®’s Educated Patient® Summit on Multiple Myeloma, Yee, an assistant professor of medicine at Massachusetts General Hospital Cancer Center in Boston, discussed the signs and symptoms of...
Continue Reading
This article was originally published on Wiley Online Library There are currently limited Australian data on the outcomes of autologous stem cell transplantation (ASCT) in elderly multiple myeloma (MM) patients. We present the largest cohort of elderly MM patients aged ≥65 years undergoing ASCT in Australia and report their outcomes based on our two‐centre experience. Our...
Continue Reading
1 2 3 31

Floor 7, 90 The Terrace
Wellington Central
New Zealand